UFL Group proudly participated in KIMES 2025, Seoul’s premier medical equipment and healthcare exhibition, engaging with Korean innovators specializing in injectable medical products, such as hyaluronic acid fillers and skin boosters. These cutting-edge solutions are poised to capture the rapidly expanding Chinese market, where demand for premium medical aesthetics is surging. According to Millennium Research Group, China’s dermal filler market is expected to reach $1.29 billion by 2025, with an impressive annual growth rate of 15%. Navigating this opportunity, however, requires meticulous compliance with China’s stringent regulations, including CFDA certification for Class III medical devices.
At UFL Group, we empower businesses to succeed in this dynamic landscape through tailored logistics solutions. Our partnerships with industry leaders like Humedix, Siemens, Sinopharm, and Thermo Fisher enable us to deliver comprehensive services, including personalized consultations for regulatory compliance and market entry, import agency support for scalable growth, and end-to-end cold chain logistics. With GSP-certified warehousing (2–8°C and 18–25°C) and advanced temperature-controlled transport, we ensure product integrity across China, Europe, the Americas, Latin America, and Southeast Asia.
For customized support, please contact our Medical & Healthcare Project Team in Shanghai at medi@ufreight.com or visit our Contact Page. UFL Group is your trusted partner in shaping the future of medical logistics, where innovation meets reliability.
